74 related articles for article (PubMed ID: 27919959)
1. Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells.
Lee YY; Jeon HK; Lee J; Hong JE; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Kim YC; Lee JW
Anticancer Res; 2016 Dec; 36(12):6381-6388. PubMed ID: 27919959
[TBL] [Abstract][Full Text] [Related]
2. Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II.
Quan A; McGeachie AB; Keating DJ; van Dam EM; Rusak J; Chau N; Malladi CS; Chen C; McCluskey A; Cousin MA; Robinson PJ
Mol Pharmacol; 2007 Dec; 72(6):1425-39. PubMed ID: 17702890
[TBL] [Abstract][Full Text] [Related]
3. Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments.
Yamada H; Abe T; Li SA; Masuoka Y; Isoda M; Watanabe M; Nasu Y; Kumon H; Asai A; Takei K
Biochem Biophys Res Commun; 2009 Dec; 390(4):1142-8. PubMed ID: 19857461
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
5. Dynamin 2 is required for actin assembly in phagocytosis in Sertoli cells.
Otsuka A; Abe T; Watanabe M; Yagisawa H; Takei K; Yamada H
Biochem Biophys Res Commun; 2009 Jan; 378(3):478-82. PubMed ID: 19032944
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of potent chemical inhibitors of dynamin GTPase.
Lee S; Jung KY; Park J; Cho JH; Kim YC; Chang S
Bioorg Med Chem Lett; 2010 Aug; 20(16):4858-64. PubMed ID: 20621477
[TBL] [Abstract][Full Text] [Related]
7. Impact of dynasore an inhibitor of dynamin II on Shigella flexneri infection.
Lum M; Attridge SR; Morona R
PLoS One; 2013; 8(12):e84975. PubMed ID: 24367704
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo.
Liu Y; Zhang X; An S; Wu Y; Hu G; Wu Y
Cancer Chemother Pharmacol; 2015 Mar; 75(3):465-74. PubMed ID: 25552400
[TBL] [Abstract][Full Text] [Related]
9. The Dynamin 2 inhibitor Dynasore affects the actin filament distribution during mouse early embryo development.
Wang QC; Liu J; Duan X; Cui XS; Kim NH; Xiong B; Sun SC
J Reprod Dev; 2015; 61(1):49-53. PubMed ID: 25421092
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 expression.
Hussain A; Harish G; Prabhu SA; Mohsin J; Khan MA; Rizvi TA; Sharma C
Cancer Epidemiol; 2012 Dec; 36(6):e387-93. PubMed ID: 22884883
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activity of staurosporine in the tumor microenvironment of cervical cancer: An in vitro study.
Yadav SS; Prasad CB; Prasad SB; Pandey LK; Singh S; Pradhan S; Narayan G
Life Sci; 2015 Jul; 133():21-8. PubMed ID: 26006035
[TBL] [Abstract][Full Text] [Related]
12. The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells.
Joshi S; Perera S; Gilbert J; Smith CM; Mariana A; Gordon CP; Sakoff JA; McCluskey A; Robinson PJ; Braithwaite AW; Chircop M
Mol Cancer Ther; 2010 Jul; 9(7):1995-2006. PubMed ID: 20571068
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
Gynecol Oncol; 2007 Aug; 106(2):400-6. PubMed ID: 17512576
[TBL] [Abstract][Full Text] [Related]
14. N'-[4-(dipropylamino)benzylidene]-2-hydroxybenzohydrazide is a dynamin GTPase inhibitor that suppresses cancer cell migration and invasion by inhibiting actin polymerization.
Yamada H; Abe T; Li SA; Tago S; Huang P; Watanabe M; Ikeda S; Ogo N; Asai A; Takei K
Biochem Biophys Res Commun; 2014 Jan; 443(2):511-7. PubMed ID: 24316215
[TBL] [Abstract][Full Text] [Related]
15. [Effects of lanthanum chloride on proliferation and migration of human cervical cancer cell line HeLa cells].
Liu SS; Lu D; Miao LF; Xiong QY; Chen XP; Wang Y; Guo F
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):609-13. PubMed ID: 21029618
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
Kockx M; Karunakaran D; Traini M; Xue J; Huang KY; Nawara D; Gaus K; Jessup W; Robinson PJ; Kritharides L
PLoS One; 2014; 9(10):e111186. PubMed ID: 25347775
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer.
Fan D; Wang Y; Qi P; Chen Y; Xu P; Yang X; Jin X; Tian X
Gynecol Oncol; 2016 Apr; 141(1):166-74. PubMed ID: 26873866
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.
Prusty BK; Das BC
Int J Cancer; 2005 Mar; 113(6):951-60. PubMed ID: 15514944
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
